StockData
Inogen Inc logo

Inogen Inc (INGN) stock

INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3068% below fair value
$5.68+0.05 (+0.98%)

Close on Nov 17, 2026Market cap $150.87MP/E –Yield –

Inogen r&d expenses

Research and development expenses are spending on new products and technology.

Inogen's R&D Expenses for the twelve months ending Jun 30, 2026 was $21.12M, up 13.2% year over year. For fiscal 2025 it was $19.40M, down 10.2% from the year before. Over ten years it grew 16.6% a year on average. The highest annual figure on record is $21.94M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$19.40M-10.2%
FY2024Dec 31, 2024$21.61M+3.7%
FY2023Dec 31, 2023$20.84M-5.0%
FY2022Dec 31, 2022$21.94M+32.4%
FY2021Dec 31, 2021$16.58M+17.7%
FY2020Dec 31, 2020$14.08M+49.8%
FY2019Dec 31, 2019$9.40M+33.7%
FY2018Dec 31, 2018$7.03M+32.3%
FY2017Dec 31, 2017$5.31M+3.9%
FY2016Dec 31, 2016$5.11M+22.3%
FY2015Dec 31, 2015$4.18M+40.4%
FY2014Dec 31, 2014$2.98M+24.1%
FY2013Dec 31, 2013$2.40M+6.0%
FY2012Dec 31, 2012$2.26M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.87M+12.7%
Q1 FY2026Mar 31, 2026$5.10M+26.4%
Q4 FY2025Dec 31, 2025$5.32M-9.9%
Q3 FY2025Sep 30, 2025$4.84M+37.6%
Q2 FY2025Jun 30, 2025$5.21M-7.2%
Q1 FY2025Mar 31, 2025$4.03M-38.7%
Q4 FY2024Dec 31, 2024$5.90M-12.2%
Q3 FY2024Sep 30, 2024$3.52M-21.6%
Q2 FY2024Jun 30, 2024$5.62M+30.8%
Q1 FY2024Mar 31, 2024$6.58M+23.1%
Q4 FY2023Dec 31, 2023$6.71M+13.1%
Q3 FY2023Sep 30, 2023$4.49M-2.0%
Q2 FY2023Jun 30, 2023$4.29M-29.2%
Q1 FY2023Mar 31, 2023$5.34M-0.4%
Q4 FY2022Dec 31, 2022$5.93M+26.7%
Q3 FY2022Sep 30, 2022$4.58M+22.0%
Q2 FY2022Jun 30, 2022$6.06M+47.1%
Q1 FY2022Mar 31, 2022$5.36M+33.6%
Q4 FY2021Dec 31, 2021$4.68M+27.5%
Q3 FY2021Sep 30, 2021$3.75M+6.9%
Q2 FY2021Jun 30, 2021$4.12M+25.3%
Q1 FY2021Mar 31, 2021$4.02M+11.4%
Q4 FY2020Dec 31, 2020$3.67M+1.3%
Q3 FY2020Sep 30, 2020$3.51M+33.2%
Q2 FY2020Jun 30, 2020$3.29M+124.1%
Q1 FY2020Mar 31, 2020$3.61M+116.0%
Q4 FY2019Dec 31, 2019$3.63M+108.3%
Q3 FY2019Sep 30, 2019$2.64M+25.8%
Q2 FY2019Jun 30, 2019$1.47M-17.3%
Q1 FY2019Mar 31, 2019$1.67M+17.9%
Q4 FY2018Dec 31, 2018$1.74M+27.2%
Q3 FY2018Sep 30, 2018$2.10M+52.4%
Q2 FY2018Jun 30, 2018$1.78M+40.9%
Q1 FY2018Mar 31, 2018$1.42M+8.2%
Q4 FY2017Dec 31, 2017$1.37M+12.6%
Q3 FY2017Sep 30, 2017$1.38M+1.9%
Q2 FY2017Jun 30, 2017$1.26M–
Q1 FY2017Mar 31, 2017$1.31M–
Q4 FY2016Dec 31, 2016$1.22M–
Q3 FY2016Sep 30, 2016$1.35M–

More Inogen figures

See a number that looks wrong?